Matches in Nanopublications for { ?s ?p "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP520974.RAsxdSMzX6kcnHZsPA5QsSWw_i__30K2IiaxzS-cnkOs0130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520974.RAsxdSMzX6kcnHZsPA5QsSWw_i__30K2IiaxzS-cnkOs0130_provenance.
- assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100189.RAdcoMY_F0jwukGX_uEnqHcvGnQSkSIdkJkCaqz_B0e7Q130_provenance.
- NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_provenance.
- NP546384.RAsTPicjvCMTQhRJ2ojdItEedxlNocffX1xdlgf0vwlts130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546384.RAsTPicjvCMTQhRJ2ojdItEedxlNocffX1xdlgf0vwlts130_provenance.
- NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540956.RA9MnEWhyEX8bj8KvX6ZjbiRiH4l_-PUAHF07xw-YurHw130_provenance.
- NP546385.RAE5fi-QHcvJ0u4u1ahT1B4IDLCg_bDm_iFjl2HEH3ppM130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546385.RAE5fi-QHcvJ0u4u1ahT1B4IDLCg_bDm_iFjl2HEH3ppM130_provenance.